Wannada Laisuan

Wannada Laisuan

Auto-generated profile, based on publicly available information

Wannada Laisuan

Division of Allergy Immunology and Rheumatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2022 in Life
Verified
Journal Article
Open access
PDF file
YRYanisa Ratanapokasatit
Yanisa Ratanapokasatit
WLWannada Laisuan
Wannada Laisuan
TRTeerapong Rattananukrom
Teerapong Rattananukrom
APAisawan Petchlorlian
Aisawan Petchlorlian
ITIyarit Thaipisuttikul
Iyarit Thaipisuttikul
MSMongkhon Sompornrattanaphan
Mongkhon Sompornrattanaphan
The skin has a multifactorial aging process, caused by both intrinsic and extrinsic factors. A major theory of aging involves cellular senescence or apoptosis resulting from oxidative damage as the skin’s antioxidant system tends to weaken with age. The human microbiota is a complex ecosystem that is made up of microorganisms (bacteria, fungi, and viruses). Both gut and skin microbiota have essential roles in the protection against invading pathogens, mediating inflammatory conditions, and the modulation of the immune system which is involved in both innate and adaptive immune responses. However, the human microbiome could be changed during the life stage and affected by various perturbations. An alteration of the intestinal bacteria results in “microbial dysbiosis” which is associated with the influence of various diseases, including aging. The skin interactome is a novel integration of the “genome-microbiome-exposome” that plays a significant role in skin aging and skin health. Mitigating the negative impacts of factors influencing the skin interactome should be the future strategy to protect, prevent, and delay skin aging along with preserving healthy skin conditions. This review summarizes the current evidence on how human microbiomes affect skin aging and demonstrates the possible interventions, relating to human microbiomes, to modulate skin health and aging. Probiotics-based products are currently available mainly for the add-on treatment of many dermatologic conditions. However, at this point, there are limited clinical studies on skin anti-aging purposes and more are required as this evolving concept is on the rise and might provide an insight into future therapeutic options.

1 April 2018 in Asia Pacific Allergy
Verified
Journal Article
Open access
SOSupa Oncham
Supa Oncham
UUUmaporn Udomsubpayakul
Umaporn Udomsubpayakul
WLWannada Laisuan
Wannada Laisuan
The global prevalence of allergic rhinitis, asthma, and atopic dermatitis has risen significantly over the last 2 decades. Allergic sensitization to aeroallergen is a major risk factor in developing the allergic disease. The prevalence of aeroallergen sensitization varies in different regions and countries. To determine the prevalence of common aeroallergen sensitization and the atopic status among adult patients. A cross-sectional, retrospective study. The data were collected from medical records and database of the result of skin prick test of patients who had the allergic symptoms or chronic urticaria in adult allergy clinic, Ramathibodi hospital from January 2004 to December 2015. A total of 1,516 of patients (female, 1,118 [73.7%]) were enrolled. The mean ages of participants were 41.34 (standard deviation, ±16.5) years. Fifty-eight percent (58%) of patients were diagnosed with allergic rhinitis, 19.7%, 3.2%, and 9.2% with asthma, atopic dermatitis, and chronic urticaria respectively. In the chronic urticaria group, 57.4% underwent the positive skin prick test to common aeroallergens. Mites were responsible for the most common inhaled allergen sensitization in this study as 50.1% of Dermatophagoides pteronyssinus, 32% of Dermatophagoides farinae, and 31.5% of house dust. Cockroach was the second most common aeroallergen sensitization as 32.3% followed by grass pollen, Bermuda (21.1%) and timothy (13.6%). The animal dander, cat and dog, occupied 12.9 and 10% respectively. Mites were the most common cause of aeroallergen sensitization in all patients followed by cockroach, grass pollen, and animal dander. However, Bermuda sensitization has increased significantly in the last 6 years.

1 October 2021 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
WLWannada Laisuan
Wannada Laisuan
CWChamard Wongsa
Chamard Wongsa
CCChirawat Chiewchalermsri
Chirawat Chiewchalermsri
TTTorpong Thongngarm
Torpong Thongngarm
TRTicha Rerkpattanapipat
Ticha Rerkpattanapipat
MSMongkhon Sompornrattanaphan
Mongkhon Sompornrattanaphan
Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option.

1 April 2017 in Asia Pacific Allergy
Verified
Journal Article
Open access
PDF file
WLWannada Laisuan
Wannada Laisuan
CWChamard Wongsa
Chamard Wongsa
NDNizchapha Dchapaphapeaktak
Nizchapha Dchapaphapeaktak
MTMalinee Tongdee
Malinee Tongdee
JCJidapa Chatmapanrangsee
Jidapa Chatmapanrangsee
TRTicha Rerkpattanapipat
Ticha Rerkpattanapipat
Laisuan W, et al. Asia Pac Allergy. 2017 Apr;7(2):115-118. https://doi.org/10.5415/apallergy.2017.7.2.115

23 December 2021 in Frontiers in Allergy
Verified
Journal Article
Open access
WLWannada Laisuan
Wannada Laisuan
Vaccine anaphylaxis is rare; however, severe allergic reactions after administration of a coronavirus disease 2019 (COVID-19) vaccines have been reported. Excipients in the vaccine may play a role in severe allergic reactions post-vaccination. Various mechanisms, including IgE-mediated pathways, direct mass cell stimulation via the Mas-related G protein-coupled receptor-X2, and complement pathway activation, have been proposed to cause the anaphylaxis. Skin testing, using the basophil activation test, has been used to clarify the mechanism of the anaphylaxis and provide safety information for the next injection. Here, we review the current evidence and suggested approaches for patients who experienced an immediate severe allergic reaction to the first dose of a COVID-19 vaccine.

1 January 2020 in Asia Pacific Allergy
Verified
Journal Article
Open access
PDF file
RTRatchataporn Thongkhom
Ratchataporn Thongkhom
SOSupa Oncham
Supa Oncham
MSMongkhon Sompornrattanaphan
Mongkhon Sompornrattanaphan
WLWannada Laisuan
Wannada Laisuan
Thongkhom R, et al. Asia Pac Allergy. 2020 Jan;10:e4. https://doi.org/10.5415/apallergy.2020.10.e4